Rita Mozzi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Rita Mozzi has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Angela Gambelunghe
Department of Medicine, University of Perugia, 06123 Perugia, Italy
1 shared publication - Cristina Marchetti
Department of Veterinary Science, University of Parma, 43126 Parma, Italy
1 shared publication - Giacomo Muzi
Department of Medicine, University of Perugia, 06132 Perugia, Italy
1 shared publication Giuseppina Ferrara
From the Department of Experimental and Clinical Medicine, Section of Occupational Medicine, University of Perugia, Piazzale G. Menghini 3 (Drs Gambelunghe, Murgia, and Muzi), Perugia, Italy
1 shared publication- Nicola Murgia
Department of Environmental and Prevention Sciences University of Ferrara Ferrara Italy
1 shared publication - Sandra Buratta
Department of Chemistry, Biology and Biotechnology, University of Perugia, 06100 Perugia, Italy
1 shared publication
Latest Publications
- 1 July 2011
- Published by Wolters Kluwer Health in Journal of Occupational and Environmental Medicine
- Vol. 53 (7) , 776-781
Phosphatidylserine Metabolism in Human Lymphoblastic Cells Exposed to Chromium (VI)
Hexavalent chromium (Cr(VI)) compounds are widely found in different working environments. These compounds can cause apoptosis in human cells, but the mechanisms underlying chromium-induced apoptosis are not clear. A marker of apoptosis is the exposure of phosphatidylserine on cell membrane and the modification of phosphatidylserine metabolism. The aim of this study was to verify whether chromium could cause phosphatidylserine exposure and modification of its metabolism in human lymphoblastic leukemia cell line (MOLT-4). Phosphatidylserine exposure was evaluated by annexin V binding whereas phosphatidylserine metabolism was studied measuring the incorporation of [3H]serine. Cell treatment with Cr(VI) increases phosphatidylserine exposure and cell apoptosis, but decreases the incorporation of [3H]serine into phosphatidylserine in a dose- and time-dependent manner. The Cr(VI)-induced apoptosis also through modification of phosphatidylserine exposure and metabolism.
- 1 July 2011
- Published by Wolters Kluwer Health in Journal of Occupational and Environmental Medicine
- Vol. 53 (7) , 776-781
Phosphatidylserine Metabolism in Human Lymphoblastic Cells Exposed to Chromium (VI)
Hexavalent chromium (Cr(VI)) compounds are widely found in different working environments. These compounds can cause apoptosis in human cells, but the mechanisms underlying chromium-induced apoptosis are not clear. A marker of apoptosis is the exposure of phosphatidylserine on cell membrane and the modification of phosphatidylserine metabolism. The aim of this study was to verify whether chromium could cause phosphatidylserine exposure and modification of its metabolism in human lymphoblastic leukemia cell line (MOLT-4). Phosphatidylserine exposure was evaluated by annexin V binding whereas phosphatidylserine metabolism was studied measuring the incorporation of [3H]serine. Cell treatment with Cr(VI) increases phosphatidylserine exposure and cell apoptosis, but decreases the incorporation of [3H]serine into phosphatidylserine in a dose- and time-dependent manner. The Cr(VI)-induced apoptosis also through modification of phosphatidylserine exposure and metabolism.